Petco Health and Wellness Company, Inc. (FRA:7G9)
Germany · Delayed Price · Currency is EUR 2.361
-0.073 (-3.00%)
Last updated: Jan 27, 2026, 5:00 PM CET
FRA:7G9 Income Statement
Financials in millions USD. Fiscal year is March - February.
Millions USD. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 1, 2025 | Feb '25 Feb 1, 2025 | Feb '24 Feb 3, 2024 | Jan '23 Jan 28, 2023 | Jan '22 Jan 29, 2022 | Jan '21 Jan 30, 2021 |
| 5,998 | 6,116 | 6,255 | 6,036 | 5,807 | 4,920 | |
Revenue Growth (YoY) | -3.85% | -2.22% | 3.63% | 3.94% | 18.03% | 10.95% |
Cost of Revenue | 3,685 | 3,792 | 3,901 | 3,609 | 3,372 | 2,813 |
Gross Profit | 2,314 | 2,324 | 2,354 | 2,427 | 2,435 | 2,107 |
Selling, General & Admin | 2,199 | 2,309 | 2,309 | 2,199 | 2,143 | 1,898 |
Operating Expenses | 2,199 | 2,309 | 2,309 | 2,199 | 2,143 | 1,898 |
Operating Income | 114.76 | 15.84 | 45.04 | 227.76 | 291.77 | 208.92 |
Interest Expense | -133.73 | -143.53 | -150.91 | -101.64 | -77.4 | -219.08 |
Interest & Investment Income | 5.36 | 3.71 | 3.41 | 1.03 | 0.06 | 0.65 |
Earnings From Equity Investments | 18.68 | 18.67 | 16.19 | 12.98 | 10.88 | 6.48 |
Other Non Operating Income (Expenses) | -5.8 | - | - | - | - | - |
EBT Excluding Unusual Items | -0.74 | -105.31 | -86.27 | 140.12 | 225.32 | -3.02 |
Merger & Restructuring Charges | - | - | - | - | -15.3 | - |
Impairment of Goodwill | - | - | -1,223 | - | - | - |
Gain (Loss) on Sale of Investments | 4.8 | 4.8 | 4.73 | -12.67 | 34.5 | - |
Asset Writedown | -8.79 | -8.79 | -2.83 | -2.2 | -10.4 | -14.5 |
Other Unusual Items | - | - | -0.92 | - | -20.84 | -17.55 |
Pretax Income | -4.73 | -109.3 | -1,308 | 125.26 | 213.28 | -35.07 |
Income Tax Expense | -2.53 | -7.48 | -27.61 | 35.35 | 53.47 | -3.34 |
Earnings From Continuing Operations | -2.2 | -101.82 | -1,280 | 89.91 | 159.81 | -31.74 |
Minority Interest in Earnings | - | - | - | 0.89 | 4.61 | 5.25 |
Net Income | -2.2 | -101.82 | -1,280 | 90.8 | 164.42 | -26.48 |
Net Income to Common | -2.2 | -101.82 | -1,280 | 90.8 | 164.42 | -26.48 |
Net Income Growth | - | - | - | -44.77% | - | - |
Shares Outstanding (Basic) | 278 | 273 | 268 | 266 | 264 | 211 |
Shares Outstanding (Diluted) | 278 | 273 | 268 | 266 | 265 | 211 |
Shares Change (YoY) | 2.51% | 2.19% | 0.60% | 0.23% | 25.94% | 0.84% |
EPS (Basic) | -0.01 | -0.37 | -4.78 | 0.34 | 0.62 | -0.13 |
EPS (Diluted) | -0.01 | -0.37 | -4.78 | 0.34 | 0.62 | -0.13 |
EPS Growth | - | - | - | -45.16% | - | - |
Free Cash Flow | 129.61 | 49.68 | -9.88 | 67.98 | 119.11 | 109.06 |
Free Cash Flow Per Share | 0.47 | 0.18 | -0.04 | 0.26 | 0.45 | 0.52 |
Gross Margin | 38.57% | 38.00% | 37.63% | 40.21% | 41.93% | 42.82% |
Operating Margin | 1.91% | 0.26% | 0.72% | 3.77% | 5.02% | 4.25% |
Profit Margin | -0.04% | -1.67% | -20.47% | 1.50% | 2.83% | -0.54% |
Free Cash Flow Margin | 2.16% | 0.81% | -0.16% | 1.13% | 2.05% | 2.22% |
EBITDA | 313.53 | 215.57 | 245.83 | 421.59 | 464.2 | 383.76 |
EBITDA Margin | 5.23% | 3.52% | 3.93% | 6.98% | 7.99% | 7.80% |
D&A For EBITDA | 198.78 | 199.73 | 200.78 | 193.83 | 172.43 | 174.84 |
EBIT | 114.76 | 15.84 | 45.04 | 227.76 | 291.77 | 208.92 |
EBIT Margin | 1.91% | 0.26% | 0.72% | 3.77% | 5.02% | 4.25% |
Effective Tax Rate | - | - | - | 28.22% | 25.07% | - |
Revenue as Reported | 5,998 | 6,116 | 6,255 | 6,036 | 5,807 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.